Form 4: Privia Health Group Director Thomas A. McCarthy Reports Stock Transactions

Director Thomas A. McCarthy reports acquisition of 10,000 shares and receipt of 11,124 restricted stock units of Privia Health Group, Inc.

Summary

• On May 22, 2024, Thomas A. McCarthy, a director of Privia Health Group, Inc., received 11,124 restricted stock units (RSUs) under the company's 2021 Omnibus Incentive Plan.
• These RSUs will vest on the earlier of the day immediately preceding the company's 2025 annual meeting of stockholders or the first anniversary of the grant date.
• On May 23, 2024, McCarthy also acquired 10,000 shares of common stock at a price of $16.37 per share.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock transactions by a company director. The purchase of shares could be seen as slightly positive, but overall, it's a routine filing.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
• The vesting of restricted stock units incentivizes the director to contribute to the company's long-term success.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of RSUs in 2025 suggests a focus on long-term performance.

Industry Context

This type of filing is standard for corporate insiders and provides transparency into their investment activities in the company. It's common for directors to receive stock-based compensation and make open market purchases.

Stakeholder Impact

• The stock purchase by a director may have a minor positive impact on shareholder confidence.

Key Dates